Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.84 USD | +7.42% | -3.16% | -23.75% |
May. 20 | Chinese Regulator Approves Zai Lab’s New Drug Application for Bacterial Pneumonia Drug | MT |
May. 20 | Zai Lab, Innoviva Subsidiary Receive China Approval for Hospital Infection Treatment | MT |
ETFs positioned on Zai Lab Limited
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.29% | 4 M€ | -27.92% | ||
1.04% | 2 M€ | -13.00% | - | |
0.75% | 96 M€ | -.--% | - | |
0.27% | 0 M€ | 0.00% | - | |
0.21% | 0 M€ | 0.00% | - | |
0.07% | 35 M€ | -5.85% | - | |
0.03% | 112 M€ | +5.31% | - | |
0.01% | 32 M€ | +9.19% | - | |
0.00% | 7 M€ | +6.59% | - | |
0.00% | 34 M€ | +9.12% | - | |
0.00% | 391 M€ | +9.67% | - | |
0.00% | 39 M€ | +6.43% | - | |
0.00% | 306 M€ | +6.54% | - | |
0.00% | 7 M€ | +0.11% | - | |
0.00% | 105 M€ | +4.05% | - | |
0.00% | 17 M€ | +3.40% | - | |
0.00% | 15 M€ | +20.48% | ||
0.00% | 54 M€ | +0.94% | - | |
0.00% | 8 M€ | +1.17% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.75% | 1.92B | |
-3.05% | 90.45B | |
+3.95% | 41.45B | |
-10.51% | 33.57B | |
+60.58% | 25.73B | |
-20.09% | 14.73B | |
-8.92% | 12.82B | |
-11.46% | 11.7B | |
-43.05% | 11.44B | |
+5.17% | 8.79B |
- Stock Market
- Equities
- ZLAB Stock
- Funds and ETFs Zai Lab Limited